Expression of neural RGS-R7 and Gβ5 proteins in response to acute and chronic morphine

Neuropsychopharmacology

Volumn 30, Issue 1, 2005, Pages 99-110

  López Fando, Almudena ^a   Rodríguez Muñoz, María ^a   Sánchez Blázquez, Pilar ^a   Garzón, Javier ^a,b  

^a CSIC   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Acute tolerance; G 5 protein; G proteins; Morphine; Opioid tolerance; R7 subfamily of RGS proteins; Regulator of G protein signaling

Indexed keywords

BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MORPHINE; PROTEIN G BETA5; RGS PROTEIN; RGS11 PROTEIN; RGS6 PROTEIN; RGS7 PROTEIN; RGS9 2 PROTEIN; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; IMMUNOBLOTTING; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIAQUEDUCTAL GRAY MATTER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THALAMUS; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN CHEMISTRY; DRUG IMPLANTS; DRUG TOLERANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GTP-BINDING PROTEIN BETA SUBUNITS; IMMUNOBLOTTING; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MORPHINE; NARCOTICS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; OPIOID-RELATED DISORDERS; PERIAQUEDUCTAL GRAY; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA, MESSENGER;

EID: 11144341921     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300515     Document Type: Article

References (65)

1. Azaryan AV, Clock BJ, Cox BM (1996a). Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation. Neurochem Res 21: 1411-1415.
2. Azaryan AV, Coughlin LJ, Buzas B, Clock BJ, Cox BM (1996b). Effect of chronic cocaine treatment on μ- and δ-opioid receptor mRNA levels in dopaminergically innervated brain regions. J Neurochem 66: 443-448.
3. Benzing T, Brandes R, Seilin L, Schermer B, Lacker S, Walz G et al (1999). Upregulation of RGS7 may contribute to tumour necrosis factor-induced changes in central nervous function. Nat Med 5: 913-918.
4. Benzing T, Yaffe MB, Arnould T, Sellin L, Schermer B, Schilling B et al (2000). 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem 275: 28167-28172.
5. Betty M, Harnish SW, Rhodes KJ, Cockett MI (1998). Distribution of heterotrimeric G-protein β and y subunits in the rat brain. Neuroscience 85: 475-486.
6. Bishop G, Cullinan W, Curran E, Gutstein H (2002). Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol Dis 10: 334-343.
7. Bower CM, Hyde TM, Zaka M, Hamid EH, Baca SM, Egan MF (2000). Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol. Psychopharmacology 150: 260-263.
8. Boylan MK, Fisher RS, Hull CD, Buchwald NA, Levine MS (1986). Axonal branching of basal forebrain projections to the neocortex: a double-labelling study in the cat. Brain Res 375: 176-181.
9. Brodsky M, Elliot K, Hynansky A, Jenab S, Inturrisi CE (1995a). Quantitation of mu-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS. Neuroreport 6: 725-729.
10. Brodsky M, Elliot K, Hynansky A, Jenab S, Inturrisi CE (1995b). CNS levels of mu-opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res Bull 38: 135-141.
11. Burchett SA, Bannon MJ, Granneman JG (1999). RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J Neurochem 72: 15219-15330.
12. Burchett SA, Volk ML, Bannon MJ, Granneman JG (1998). Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. J Neurochem 70: 2216-2219.
13. Buzas B, Rosenberger J, Cox BM (1996). Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 7: 1505-1508.
14. Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL (1997). Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA in the rat brain. Brain Res Mol Brain Res 45: 149-153.
15. Chen C-K, Burns ME, He W, Wensel TG, Baylor DA, Simon MI (2000). Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 403: 557-560.
16. Chen C-K, Eversole-Cire P, Zhang H, Mancino V, Chen Y-J, He W et al (2003). Instability of GGL domain-containing RGS proteins in mice lacking the G protein β-subunit Gβ5. Proc Natl Acad Sci USA 100: 6604-6609.
17. Chen JF, Aloyo VJ, Qin ZH, Weiss B (1994). Irreversible blockade of D2 dopamine receptor by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in striatum. Neurochem Int 25: 355-366.
18. Delfs JM, Yu L, Ellison GD, Reisine T, Chesselet M-F (1994). Regulation of μ-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration. J Neurochem 63: 777-780.
19. Garnier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rhee M-H et al (2003). Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine. J Pharmacol Exp Ther 304: 1299-1306.
20. Garzón J, López-Fando A, Sánchez-Blázquez P (2003). The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at μ-opioid receptors. Neuropsychopharmacology 28: 1983-1990 (advance online publication, 6 August 2003 (DOI:10.1038/sj.npp.1300263)).
21. Garzón J, Rodríguez-Díaz M, López-Fando A, García-España A, Sánchez-Blázquez P (2002). Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology 42: 813-828.
22. Garzón J, Rodríguez-Muñoz M, López-Fando A, García-España A, Sánchez-Blázquez P (2004). RGSZ1 and GAIP regulate μ- but not δ-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology (advance online publication, 3 March 2004 (DOI:10.1038/sj.npp.1300408)).
23. Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001). RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13: 801-811.
24. Garzón J, Sánchez-Blázquez P (2001). Administration of myr+-Gi2α subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice. Neuropharmacology 40: 560-569.
25. Georges F, Stinus L, Bloch B, La Moine C (1999). Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 11: 481-490.
26. Geurts M, Hermans E, Maloteaux J-M (2002). Opposite modulation of regulators of G protein signalling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum. Neurosci Lett 333: 146-150.
27. Gold SJ, Han M-H, Herman AE, Ni YG, Pudiak CM, Aghajanian GK et al (2003). Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 17: 971-980.
28. Gold SJ, Heifets BD, Pudiak CM, Potts BW, Nestler EJ (2002). Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J Neurochem 82: 828-838.
29. Gold SJ, Ni YG, Dohlman HG, Nestler EJ (1997). Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037.
30. Hepler JR (1999). Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci 20: 376-382.
31. Hollinger S, Hepler JR (2002). Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54: 527-559.
32. Hoover JE, Strick PL (1993). Multiple output channels in the basal ganglia. Science 259: 819-821.
33. Huidobro F, Huidobro-Toro JP, Way EL (1976). Studies on tolerance development to single doses of morphine in mice. J Pharmacol Exp Ther 198: 318-326.
34. Huidobro-Toro JP, Way EL (1978). Single-dose tolerance to antinociception, and physical dependence on β-endorphin in mice. Eur J Pharmacol 52: 179-189.
35. Kim E, Arnould T, Seilin L, Benzing T, Comella N, Kocher O et al (1999). Interaction between RGS7 and polycystin. Proc Natl Acad Sci USA 96: 6371-6376.
36. Magendzo K, Bustos G (2003). Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors. Neuropsychopharmacology 28: 468-477 (advance on-line publication, 13 September 2002 (DOI:10.1038/sj.npp.1300063)).
37. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H et al (1994). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438.
38. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
39. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001). Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6: 293-301.
40. Nakagawa T, Minami M, Satoh M (2001). Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors. Eur J Pharmacol 433: 29-36.
41. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ (1999). Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 19: 3674-3680.
42. Park Y, Ho IK, Fan LW, Loh HH, Ko KH (2001). Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of mu-opioid receptor knockout mice. Brain Res 894: 311-315.
43. Potenza MN, Gold SJ, Roby-Shemkowitz A, Lerner MR, Nestler EJ (1999). Effects of regulators of G-protein-signalling proteins on the functional response of the μ-opioid receptor in a melanophore-based assay. J Pharmacol Exp Ther 291: 482-491.
44. Rahman Z, Gold SJ, Potenza MN, Cowan CW, Ni YG, He W et al (1999). Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci 19: 2016-2026.
45. Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi K-H et al (2003). RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38: 941-952.
46. Robinet EA, Geurts M, Maloteaux JM, Pauwels PJ (2001a). Chronic treatment with certain antipsychotic drugs preserves upregulation of RGS2 mRNA in rat striatum as opposed to c-fos mRNA. Neurosci Lett 307: 45-48.
47. Robinet EA, Wurch T, Pauwels PJ (2001b). Different regulation of RGS2 mRNA by haloperidol and clozapine. Neuroreport 12: 1731-1735.
48. Rose JJ, Taylor JB, Cockett MI, Jones PG, Hepler JR (2000). RGS7 is palmitoylated and exists as biochemically distinct forms. J Neurochem 75: 2103-2112.
49. Ross EM, Wilkie TM (2000). GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69: 795-827.
50. + currents. J Biol Chem 14: 9899-9904.
51. Sánchez-Blázquez P, García-España A, Garzón J (1995). In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Exp Ther 275: 1590-1596.
52. Sánchez-Blázquez P, García-España A, Garzón J (1997). Antisense oligodeoxynucleotides to opioid Mu and DELTA receptors reduced morphine dependence in mice: role of DELTA2 opioid receptors. J Pharmacol Exp Ther 280: 1423-1431.
53. Sánchez-Blázquez P, Rodríguez-Díaz M, López-Fando A, Rodríguez-Muñoz M, Garzón J (2003). The GBetaS subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects. Neuropharmacology 45: 85-98.
54. Saper CB (1985). Organization of cerebral cortical afferent systems in the rat. II. Hypothalamocortical projections. J Comp Neurol 237: 21-46.
55. Shuey DJ, Betty M, Jones PG, Khawaja XZ, Cockett MI (1998). RGS7 attenuates signal transduction through the Gαq family of heterotrimeric G proteins in mammalian cells. J Neurochem 70: 1964-1972.
56. Snow BE, Betts L, Mangion J, Sondek J, Siderovski DP (1999). Fidelity of G protein β-subunit association by the protein γ-subunit-like domains of RGS6, RGS7, and RGS11. Proc Natl Acad Sci USA 96: 6489-6494.
57. Snow BE, Krumins AM, Brothers GM, Lee S-F, Wall MA, Chung S et al (1998). A G protein γ subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gβ5 subunits. Proc Natl Acad Sci USA 95: 13307-13312.
58. Taymans J-M, Leysen JE, Langlois X (2003). Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J Neurochem 84: 1118-1127.
59. Vecchiola A, Collyer P, Figueroa R, Labarca R, Bustos G, Magendzo K (1999). Differential regulation of mu-opioid receptor mRNA in the nucleus accumbens shell and core accompanying amphetamine behavioral sensitization. Brain Res Mol Brain Res 69: 1-9.
60. Wang H, Wessendorf MW (2002). Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla. Neuroscicence 109: 619-634.
61. Watson AJ, Aragay AM, Slepak VZ, Simon MI (1996). A novel form of the G protein β subunit Gβ5 is specifically expressed in the vertebrate retina. J Biol Chem 271: 28154-28160.
62. Witherow DS, Wang Q, Levay K, Cabrera JL, Chen J, Willars GB et al (2000). Complexes of the G protein subunit Gβ5 with the regulators of G protein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells. J Biol Sci 275: 24872-24880.
63. Yaksh TL, Yeung JC, Rudy TA (1976). Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res 114: 83-103.
64. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O et al (2003). Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 100: 13656-13661.
65. Zhang JH, Simonds WF (2000). Copurification of brain G-protein β5 with RGS6 and RGS7. J Neurosci 20: RC59 (1-5).